Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

CHARACTERIZATION OF A REPLICATION COMPETENT HUMAN IMMUNODEFICIENCY TYPE 2 PROVIRAL CLONE

  • Read more about CHARACTERIZATION OF A REPLICATION COMPETENT HUMAN IMMUNODEFICIENCY TYPE 2 PROVIRAL CLONE
US Patent 5,223,423
Filed on 1989-03-31

Chemical Differentiating Agents

  • Read more about Chemical Differentiating Agents
US Patent 4,992,472
Filed on 1989-05-01

Human Derived Monocyte Attracting Purified Protein Product Useful in a Method of Treating Infection and Neoplasm in a Human Body, and the Cloning of Full Length cDNA Thereof

  • Read more about Human Derived Monocyte Attracting Purified Protein Product Useful in a Method of Treating Infection and Neoplasm in a Human Body, and the Cloning of Full Length cDNA Thereof
US Patent 6,869,924
Filed on 1989-03-30

Metalloproteinase Inhibitor Peptides (TIMP-2)

  • Read more about Metalloproteinase Inhibitor Peptides (TIMP-2)
US Application 07/326,334
Filed on 1989-03-21

Antitumor antibiotic BMY-41339

  • Read more about Antitumor antibiotic BMY-41339
US Patent 5,028,536
Filed on 1989-03-15

COMPUTER ASSISTED-DESIGN OF ANTI-PEPTIDES BASED ON THE AMINO ACID SEQUENCE OF A TARGET PEPTIDE

  • Read more about COMPUTER ASSISTED-DESIGN OF ANTI-PEPTIDES BASED ON THE AMINO ACID SEQUENCE OF A TARGET PEPTIDE
US Patent 5,081,584
Filed on 1989-03-13

METHOD OF ANMINISTERING SURAMIN SODIUM IN THE TREATMENT OF CANCERS

  • Read more about METHOD OF ANMINISTERING SURAMIN SODIUM IN THE TREATMENT OF CANCERS
US Application 07/321,055
Filed on 1989-03-09

MATRIX METALLOPROTEINASE PEPTIDES: ROLE IN DIAGNOSIS AND THERAPY

  • Read more about MATRIX METALLOPROTEINASE PEPTIDES: ROLE IN DIAGNOSIS AND THERAPY
US Patent 5,270,447
Filed on 1989-03-01

Stabilized Nitric Oxide-Primary Amine Complexes Useful as Cardiovascular Agents

  • Read more about Stabilized Nitric Oxide-Primary Amine Complexes Useful as Cardiovascular Agents
US Patent 4,954,526
Filed on 1989-02-28

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCERS SUSCEPTIBLE TO TREATMENT WITH THE COPPER COMPLEX OF S-...

  • Read more about PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCERS SUSCEPTIBLE TO TREATMENT WITH THE COPPER COMPLEX OF S-...
US Patent 5,124,351
Filed on 1989-02-27

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1649
  • Page 1650
  • Page 1651
  • Page 1652
  • Page 1653
  • Page 1654
  • Page 1655
  • Page 1656
  • Page 1657
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health